See every side of every news story
Published loading...Updated

Trump administration drops Biden plan for Medicare to cover weight-loss drugs

  • The Trump administration announced that the Centers for Medicare and Medicaid Services will not cover weight loss drugs for obesity treatment as of April 4.
  • The Biden administration's proposal to cover these drugs was found to potentially cost taxpayers $35 billion over the next decade but was deemed 'not appropriate at this time' by a CMS spokesperson.
  • Legislation from 2003 prohibits Medicare from covering medication specifically for weight loss, impacting coverage options.
  • This decision does not affect existing coverage for drugs prescribed for diabetes, such as Ozempic and Mounjaro.
Insights by Ground AI
Does this summary seem wrong?

78 Articles

All
Left
16
Center
41
Right
11
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 60% of the sources are Center
60% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

NBC Dallas-Fort Worth broke the news in Fort Worth, United States on Friday, April 4, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.